naproxen has been researched along with Cognition Disorders in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (25.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (50.00) | 29.6817 |
| 2010's | 2 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brandt, J; Breitner, JC; Luis, CA; Martin, B; Reckess, GZ; Zandi, P | 1 |
| Breitner, JC; McCaffrey, LD; Meinert, CL | 1 |
| Jain, NK; Kulkarni, SK; Patil, CS; Singh, A | 1 |
| Kumar, A; Naidu, PS; Padi, SV; Seghal, N | 1 |
| Brandt, J; Breitner, JC; Craft, S; Evans, D; Green, R; Martin, BK; Mullan, M; Piantadosi, S; Szekely, C | 1 |
| Ames, FR | 1 |
| Goodwin, JS; Regan, M | 1 |
4 trial(s) available for naproxen and Cognition Disorders
| Article | Year |
|---|---|
Results of a follow-up study to the randomized Alzheimer's Disease Anti-inflammatory Prevention Trial (ADAPT).
Topics: Age Factors; Aged; Aged, 80 and over; Alzheimer Disease; Anti-Inflammatory Agents; Celecoxib; Cognition Disorders; Double-Blind Method; Female; Humans; Inflammation; Longitudinal Studies; Male; Naproxen; Physical Examination; Pyrazoles; Sulfonamides; Treatment Outcome | 2013 |
Screening by telephone in the Alzheimer's disease anti-inflammatory prevention trial.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Celecoxib; Cognition Disorders; Female; Geriatric Assessment; Humans; Male; Mass Screening; Naproxen; Neuropsychological Tests; Pyrazoles; Sulfonamides; Telephone | 2013 |
Alzheimer's Disease Anti-inflammatory Prevention Trial: design, methods, and baseline results.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Anti-Inflammatory Agents, Non-Steroidal; Brain; Celecoxib; Cognition Disorders; Encephalitis; Female; Humans; Male; Naproxen; Neuropsychological Tests; Outcome Assessment, Health Care; Patient Selection; Placebos; Pyrazoles; Research Design; Sulfonamides; Time; Treatment Outcome | 2009 |
Cognitive function over time in the Alzheimer's Disease Anti-inflammatory Prevention Trial (ADAPT): results of a randomized, controlled trial of naproxen and celecoxib.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Cognition; Cognition Disorders; Double-Blind Method; Female; Follow-Up Studies; Humans; Longitudinal Studies; Male; Naproxen; Pyrazoles; Sulfonamides; Time Factors; Treatment Outcome | 2008 |
4 other study(ies) available for naproxen and Cognition Disorders
| Article | Year |
|---|---|
Modulatory role of cyclooxygenase inhibitors in aging- and scopolamine or lipopolysaccharide-induced cognitive dysfunction in mice.
Topics: Aging; Animals; Anxiety; Avoidance Learning; Cognition Disorders; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Female; Gastrointestinal Diseases; Isoenzymes; Lactones; Lipopolysaccharides; Male; Membrane Proteins; Mice; Motor Activity; Muscarinic Antagonists; Naproxen; Postural Balance; Prostaglandin-Endoperoxide Synthases; Scopolamine; Sulfonamides; Sulfones | 2002 |
Differential effects of cyclooxygenase inhibitors on intracerebroventricular colchicine-induced dysfunction and oxidative stress in rats.
Topics: Acetylcholinesterase; Animals; Behavior, Animal; Brain; Cognition Disorders; Colchicine; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Disease Models, Animal; Dose-Response Relationship, Drug; Glutathione; Injections, Intraventricular; Isoxazoles; Lipid Peroxidation; Male; Maze Learning; Memory; Naproxen; Nitrites; Oxidative Stress; Rats; Rats, Wistar; Space Perception; Spatial Behavior; Sulfonamides; Time Factors | 2006 |
Cognitive dysfunction caused by non-steroidal anti-inflammatory drugs.
Topics: Aged; Aminopyrine; Anti-Inflammatory Agents; Cognition Disorders; Female; Humans; Middle Aged; Naproxen; Phenylbutazone | 1983 |
Cognitive dysfunction associated with naproxen and ibuprofen in the elderly.
Topics: Aged; Arthritis, Rheumatoid; Cognition Disorders; Female; Humans; Ibuprofen; Joint Diseases; Male; Naproxen | 1982 |